Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial.
<h4>Background</h4> <p>Negative symptoms of schizophrenia represent deficiencies in emotional responsiveness, motivation, socialisation, speech and movement. When persistent, they are held to account for much of the poor functional outcomes associated with schizophrenia. There are...
Autores principales: | Barnes, T, Leeson, V, Paton, C, Costelloe, C, Simon, J, Kiss, N, Osborn, D, Killaspy, H, Craig, T, Lewis, S, Keown, P, Ismail, S, Crawford, M, Baldwin, D, Lewis, G, Geddes, J, Kumar, M, Pathak, R, Taylor, S |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
National Institute for Health Research
2016
|
Ejemplares similares
-
Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial
por: Thomas RE Barnes, et al.
Publicado: (2016-04-01) -
Long-term antidepressant treatment for negative symptoms in schizophrenia: the actions study
por: Barnes, T, et al.
Publicado: (2017) -
Disclosing the potential impact of placebo controls in antidepressant trials
por: Stephanie C. Chen, et al.
Publicado: (2015-06-01) -
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
por: Thomas RE Barnes, et al.
Publicado: (2017-09-01) -
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
por: Crawford, A, et al.
Publicado: (2014)